biotech · Type 1 Diabetes · Coronavirus · SABS
SAB Biotherapeutics
SAB Biotherapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Gaithersburg, USA
- Founded
- 2016
- Employees
- 39
- Programs
- 8
- Drugs
- 10
- Patents
- 1
SAB Biotherapeutics clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to SAB Biotherapeutics programs — each row shows trial ID, program name, phase, status, and indication.
SAB Biotherapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for SAB Biotherapeutics.
-
SAB-142, SODIUM CHLORIDE — Phase 2
Clinical update -
Single Ascending Dose of SAB-176 — Phase 1
Clinical update -
bamlanivimab 7000mg — Phase 3
Clinical update -
SAB-185 — Phase 1
Clinical update -
SAB-176 — Phase 1
Clinical update -
SAB-176 — Phase 2
Clinical update -
High Dose SAB-142 — Phase 2
Clinical update -
SAB-301 — Phase 1
Clinical update